This is where the SURMOUNT-5 data, showing 20.2% weight loss with tirzepatide versus 13.7% with semaglutide, becomes relevant to your personal experience
GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are increasingly prescribed for type 2 diabetes and weight management
Even though Ozempic, Mounjaro and Wegovy are off the shortages list, pharmacies have reported difficulty obtaining enough of these drugs to meet demand, Davis says
Retatrutide Phase 2 Obesity Trial Investigators
For many, this step marks the completion of a long journey - a moment to celebrate wellness and reclaim the sense of self that often evolves alongside physical transformation